Literature DB >> 19758568

Pre-analytical factors that influence the interpretation of prothrombin time in the clinical laboratory: one year experience in a super speciality hospital in India.

Binita Goswami, Devika Tayal, Ranjna Chawla, V Mallika.   

Abstract

BACKGROUND: Accuracy and precision of Laboratory results is a top most priority in a clinical laboratory. Errors in Laboratory results could be due to pre-analytical, analytical and postanalytical variables. Here, we have discussed about pre-analytical variables during estimation of prothrombin time.
METHODS: 15,335 PT (prothrombin time) samples received in the department of clinical biochemistry from June 2008 to May 2009 were evaluated for the prevalence of pre-analytical errors. The prothrombin time (PT) was analyzed on automated coagulometer-ACL 7000 with thromboplastin reagent supplied by Trinity Biotech, Ireland.
RESULTS: Out of the 15,335 samples received in one year for analysis by the department, 464 samples showed the presence of pre-analytical variables and therefore, could not be assayed. Among the pre-analytical variables, inappropriate proportion between blood and anticoagulant was the most common error with a frequency of approximately 60%. Clotted samples and illegible handwriting accounted for another 15% each of the rejections respectively. Around 6% of the samples were hemolysed and another 2% were rejected due to lipemia.
CONCLUSION: Appropriate knowledge of blood sample collection is a need of an hour to have accuracy in Laboratory results.

Entities:  

Mesh:

Year:  2009        PMID: 19758568     DOI: 10.1016/j.cca.2009.09.014

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  1 in total

1.  There are considerable drawbacks to oral anticoagulant for monitoring patients at home which should lead family physicians to discuss alternative or enhanced solutions: a cross-sectional study.

Authors:  Jean Yves Le Reste; Benoit Chiron; Bernard Le Floch; Patrice Nabbe; Marie Barrais; Jacques Mansourati; Sébastien Cadier; Pierre Barraine; Claire Lietard
Journal:  BMC Cardiovasc Disord       Date:  2013-09-11       Impact factor: 2.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.